
    
      Primary criterion

        -  Hematological reconstitution and chimerism post-transplantation

      Secondary criteria

        -  Adverse effects, graft-related mortality at D90 and at 12 months, incidence and severity
           of acute and/or chronic GVH reactions

        -  Analysis of variations in post-transplantation immunological function profiles

        -  Median duration of response in therapy-responsive patients and median duration of
           stability in stabilized patients
    
  